HHS subpoenas Boston Scientific's CRM division Mass Device The US Dept. of Health & Human Services wants information on donations to charitis with ties to doctors; Taxus sales continue to slide. ...
Earnings Preview: Boston Scientific to report 3Q Forbes The 1800-patient study recorded a lower rate of complications for Xience, compared with Taxus. Boston Scientific controls about 45 percent of the US market ...
By: Zacks Equity Research Zacks.com s (BSX - Analyst Report) Taxus drug-eluting stent, and stents from Medtronic (MDT - Analyst Report) and Abbott Vascular, a division of Abbott (ABT - Analyst ...